| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Centre Européen de Recherche en Virologie et Immunologie, Institut National de la Santé et de la Recherche Médicale, Lyon, France
Proinflammatory oxidized phospholipids are generated during oxidative modification of low-density lipoproteins (LDL). The production of these proinflammatory oxidized phospholipids is controlled by secreted enzymes that circulate as proteins complexed with LDL and high-density lipoprotein. During the acute phase response to tissue injury, profound changes occur in lipoprotein enzymatic composition that alter their anti-inflammatory function. Monocytes may encounter oxidized phospholipids in vivo during their differentiation to macrophages or dendritic cells (DC). In this study we show that the presence of oxidized LDL (oxLDL) at the first day of monocyte differentiation to DC in vitro yielded phenotypically atypical cells with some functional characteristics of mature DC. Addition of oxLDL during the late stage of monocyte differentiation gave rise directly to phenotypically mature DC with reduced uptake capacity, secreting IL-12 but not IL-10, and supporting both syngeneic and allogeneic T cell stimulation. In contrast to known mediators of DC activation, oxLDL did not trigger maturation of immature DC. An intriguing possibility is that a burst of oxidized phospholipids is an endogenous activation signal for the immune system, which is tightly controlled by lipoproteins during the acute phase response.
This article has been cited by other articles:
|
|
 |
|
  J.-O Jin, H.-Y. Park, Q. Xu, J.-I. Park, T. Zvyagintseva, V. A. Stonik, and J.-Y. Kwak Ligand of scavenger receptor class A indirectly induces maturation of human blood dendritic cells via production of tumor necrosis factor-{alpha} Blood, June 4, 2009; 113(23): 5839 - 5847. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Bobik Secretory phospholipase A2 type IIA: a regulator of immune function in atherosclerosis? Cardiovasc Res, January 1, 2009; 81(1): 9 - 10. [Full Text] [PDF]
|
|
|
|
 |
|
 E. A. Van Vre, H. Bult, V. Y. Hoymans, V. F.I. Van Tendeloo, C. J. Vrints, and J. M. Bosmans Human C-Reactive Protein Activates Monocyte-Derived Dendritic Cells and Induces Dendritic Cell-Mediated T-Cell Activation Arterioscler. Thromb. Vasc. Biol., March 1, 2008; 28(3): 511 - 518. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S Ranjit and L Dazhu Potential role of dendritic cells for progression of atherosclerotic lesions. Postgrad. Med. J., September 1, 2006; 82(971): 573 - 575. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. A. Fulcher, S. T. Hashimi, E. L. Levroney, M. Pang, K. B. Gurney, L. G. Baum, and B. Lee Galectin-1-Matured Human Monocyte-Derived Dendritic Cells Have Enhanced Migration through Extracellular Matrix J. Immunol., July 1, 2006; 177(1): 216 - 226. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Sharma and D.-Z. Li Role of Dendritic Cells in Atherosclerosis Asian Cardiovasc Thorac Ann, April 1, 2006; 14(2): 166 - 169. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Rivollier, L. Perrin-Cocon, S. Luche, H. Diemer, J.-M. Strub, D. Hanau, A. van Dorsselaer, V. Lotteau, C. Rabourdin-Combe, T. Rabilloud, et al. High Expression of Antioxidant Proteins in Dendritic Cells: Possible Implications in Atherosclerosis Mol. Cell. Proteomics, April 1, 2006; 5(4): 726 - 736. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. V. Bobryshev Dendritic cells in atherosclerosis: current status of the problem and clinical relevance Eur. Heart J., September 1, 2005; 26(17): 1700 - 1704. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. A. VanderLaan and C. A. Reardon Thematic review series: The Immune System and Atherogenesis. The unusual suspects:an overview of the minor leukocyte populations in atherosclerosis J. Lipid Res., May 1, 2005; 46(5): 829 - 838. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Deforges, A. Evlashev, M. Perret, M. Sodoyer, S. Pouzol, J.-Y. Scoazec, B. Bonnaud, O. Diaz, G. Paranhos-Baccala, V. Lotteau, et al. Expression of hepatitis C virus proteins in epithelial intestinal cells in vivo J. Gen. Virol., September 1, 2004; 85(9): 2515 - 2523. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Coutant, S. Agaugue, L. Perrin-Cocon, P. Andre, and V. Lotteau Sensing Environmental Lipids by Dendritic Cell Modulates Its Function J. Immunol., January 1, 2004; 172(1): 54 - 60. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Cao, Y. V Bobryshev, R. S.A Lord, R. E.I Oakley, S. H Lee, and J. Lu Dendritic cells in the arterial wall express C1q: potential significance in atherogenesis Cardiovasc Res, October 15, 2003; 60(1): 175 - 186. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. S. Barbieri, S. Eligini, M. Brambilla, E. Tremoli, and S. Colli Reactive oxygen species mediate cyclooxygenase-2 induction during monocyte to macrophage differentiation: critical role of NADPH oxidase Cardiovasc Res, October 15, 2003; 60(1): 187 - 197. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Link and M. Bohm Potential role of dendritic cells in atherogenesis Cardiovasc Res, September 1, 2002; 55(4): 708 - 709. [Full Text] [PDF]
|
|
|
|
|
|
C. J.J Alderman, P. R Bunyard, B. M Chain, J. C Foreman, D. S Leake, and D. R Katz Effects of oxidised low density lipoprotein on dendritic cells: a possible immunoregulatory component of the atherogenic micro-environment? Cardiovasc Res, September 1, 2002; 55(4): 806 - 819. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Coutant, L. Perrin-Cocon, S. Agaugue, T. Delair, P. Andre, and V. Lotteau Mature Dendritic Cell Generation Promoted by Lysophosphatidylcholine J. Immunol., August 15, 2002; 169(4): 1688 - 1695. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
